EXAS vs HAL · rev $2.76B vs P/E 9.3, $19.05B cap
EXACT Sciences Corporation (EXAS) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
HAL does not have a complete income-statement cache yet.
EXAS currently screens at market cap $20.03B. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the EXAS and HAL stock pages for the full models.
Not investment advice.